<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li Y</submitter><funding>Fundamental Research Funds for the Central Universities</funding><funding>National Key R&amp;amp;D Program of China</funding><funding>Fund of Key Laboratory of Luminescence from Molecular Aggregates of Guangdong Province</funding><funding>Open Research Project of Military Logistics Support Department</funding><funding>National Natural Science Foundation of China</funding><funding>Natural Science Foundation of Guangdong Province</funding><pagination>e2102561</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8655165</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8(23)</volume><pubmed_abstract>Photodynamic therapy (PDT) has become a promising candidate for cancer theranostics; however, traditional photosensitizers (PSs) usually exhibit weak fluorescence and poor reactive oxygen species (ROS) generation efficiency when aggregated. Recently, aggregation-induced emission (AIE) luminogens have shown great potential in the development of novel PSs owing to their excellent aggregation-induced ROS generation (AIG-ROS) activity. However, there are still concerns that must be addressed. In this study, two near-infrared (NIR) emitters (PI and PTI) are synthesized with AIG-ROS characteristic. PTI exhibit a valuable redder emission with more effective intersystem crossing (ISC) process than PI. The two AIE-active PSs show excellent lipid droplet (LD)-specific targeting ability. The detailed</pubmed_abstract><journal>Advanced science (Weinheim, Baden-Wurttemberg, Germany)</journal><pubmed_title>Trojan Horse-Like Nano-AIE Aggregates Based on Homologous Targeting Strategy and Their Photodynamic Therapy in Anticancer Application.</pubmed_title><pmcid>PMC8655165</pmcid><funding_grant_id>BLB19J008</funding_grant_id><funding_grant_id>2019ZD04</funding_grant_id><funding_grant_id>2020A1515011542</funding_grant_id><funding_grant_id>21975077</funding_grant_id><funding_grant_id>51603127</funding_grant_id><funding_grant_id>2017YFE0132200</funding_grant_id><funding_grant_id>2019B030301003</funding_grant_id><funding_grant_id>21788102</funding_grant_id><pubmed_authors>Zhang W</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Wan Q</pubmed_authors><pubmed_authors>Hou J</pubmed_authors><pubmed_authors>Ma Y</pubmed_authors><pubmed_authors>Tang BZ</pubmed_authors><pubmed_authors>Zhang R</pubmed_authors><pubmed_authors>Hu R</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>Trojan Horse-Like Nano-AIE Aggregates Based on Homologous Targeting Strategy and Their Photodynamic Therapy in Anticancer Application.</name><description>Photodynamic therapy (PDT) has become a promising candidate for cancer theranostics; however, traditional photosensitizers (PSs) usually exhibit weak fluorescence and poor reactive oxygen species (ROS) generation efficiency when aggregated. Recently, aggregation-induced emission (AIE) luminogens have shown great potential in the development of novel PSs owing to their excellent aggregation-induced ROS generation (AIG-ROS) activity. However, there are still concerns that must be addressed. In this study, two near-infrared (NIR) emitters (PI and PTI) are synthesized with AIG-ROS characteristic. PTI exhibit a valuable redder emission with more effective intersystem crossing (ISC) process than PI. The two AIE-active PSs show excellent lipid droplet (LD)-specific targeting ability. The detailed</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2026-05-08T22:28:27.527Z</modification><creation>2022-02-11T13:49:53.197Z</creation></dates><accession>S-EPMC8655165</accession><cross_references><pubmed>34672122</pubmed><doi>10.1002/advs.202102561</doi></cross_references></HashMap>